Virginia Retirement Systems Et Al Eagle Pharmaceuticals, Inc. Transaction History

Virginia Retirement Systems Et Al

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 22, 2023	BUY	$17.74 - $31.87 $85,151 - $152,976	4,800 Added 21.92%	26,700 $519,000
Q4 2022 May 17, 2023	BUY	$24.98 - $39.77 $119,904 - $190,896	4,800 Added 28.07%	21,900 $640 Million
Q3 2022 May 16, 2023	BUY	$26.42 - $47.12 $324,966 - $579,576	12,300 Added 256.25%	17,100 $452 Million
Q4 2021 Feb 03, 2022	BUY	$45.82 - $56.9 $219,936 - $273,120	4,800 New	4,800 $244,000
Q2 2019 Jul 26, 2019	SELL	$46.61 - $58.45 $1.02 Million - $1.28 Million	-21,900 Closed	0 $0
Q1 2019 Apr 25, 2019	BUY	$38.66 - $51.82 $27,061 - $36,274	700 Added 3.3%	21,900 $1.11 Million
Q4 2018 Feb 07, 2019	BUY	$36.72 - $67.73 $341,496 - $629,889	9,300 Added 78.15%	21,200 $854,000
Q3 2018 Nov 02, 2018	BUY	$66.65 - $83.86 $99,975 - $125,790	1,500 Added 14.42%	11,900 $825,000
Q2 2018 Aug 03, 2018	BUY	$51.25 - $76.62 $533,000 - $796,848	10,400 New	10,400 $787,000

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

Stay updated on Virginia Retirement Systems Et Al with notifications on news.